Editorial introductions

Current Opinion in Allergy and Clinical Immunology was launched in 2001. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of allergy and clinical immunology are divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue. SECTION EDITORS Susan M. TarloSusan M. TarloSusan M. Tarlo is a respiratory physician at UHN, Toronto Western Hospital, Canada with a cross-appointment at St Michael's Hospital, Toronto, Canada and is a professor in the Department of Medicine at the University of Toronto, Canada with an academic cross-appointment in the University of Toronto, Dalla Lana Department of Public Health. Professor Tarlo's main clinical and research focus is on occupational lung disease, asthma and allergic respiratory disease. She has research appointments at the Gage Occupational and Environmental Health Unit, Li Ka Shing Research Institute, Toronto General Hospital Research Institute, University of Toronto Institute of Medical Science and the Centre for Research Excellence in Occupational Disease at St Michael's Hospital where she also has a WSIB occupational lung specialty clinic. Piero MaestrelliPiero MaestrelliPiero Maestrelli completed his medical degree at University of Padova, Italy, and then specialized in occupational medicine and pulmonology. He completed a two-year postdoctoral fellowship at the Institute of Occupational Medicine, University of Padova, and then a two-year research fellowship at the Department of Allergy and Clinical Immunology of the Cardiothoracic Institute, London, UK. Dr Maestrelli has written more than 200 scientific papers and book chapters, and has lectured nationally and internationally. He has been Chairman of the Interest Group on Occupational Allergy of the European Academy of Allergology and Clinical Immunology for three years. He has been Professor of Occupational Medicine at the University of Padova, Department of Cardiologic-Thoracic-Vascular Sciences and Public Health, Italy, and Director of the Unit of Occupational Medicine at the University Hospital of Padova until 2019. Mattia GiovanniniMattia GiovanniniMattia Giovannini attended the School of Pediatrics, pediatric specialties curriculum in allergy at the University of Florence, Italy. He has specialized in pediatric allergy since his university studies when he identified it as a career choice. Since then, he has been actively involved in clinical and research activities. Dr Giovannini trained in the United States and the United Kingdom. He is currently a pediatric specialist at the Meyer Children's Hospital in Florence, Italy, and employed as a junior researcher at the Department of Health Sciences, University of Florence. His research interests primarily involve pediatric anaphylaxis and immunomodulation. Isabella Annesi-MaesanoIsabella Annesi-MaesanoIsabella Annesi-Maesano holds a permanent joint appointment as Research Director at the French NIH (INSERM) and Professor of Environmental Epidemiology at the Sorbonne University, Paris, France. She also serves as the head of the Department of Epidemiology of Allergic and Respiratory diseases (EPAR) (www.epar.fr) at IPLESP INSERM and Sorbonne University. She is the recipient of many national awards for her research and publications including the FERS award and the 2018 AAAAI Phil and Barbara Liebmann Award. Professor Annesi-Maesano's research interests include the explanation of the etiopathogenesis of allergic and respiratory diseases and their comorbidities through an exposomic approach presently implemented in the frame of the EU FP7-ENV Health and Environment-wide Associations based on Large Population Surveys (HEALS) project (www.health-eu.eu), of which she is PI. She is or was involved in many other national and international projects as PI or WP leader. A special focus in her research is on the health effects of air pollution, climate change, biodiversity and microbiome impairment. The methods used are borrowed from statistics, epidemiology, multiomics, mathematical modeling and machine learning, which requires the use of data mining. In addition, we contribute to the development of connected objects. Professor Annesi-Maesano's has served in various leadership positions of international medical societies devoted to fighting allergic and respiratory health, namely ERS, ATS, WAO and EAACI. She has also contributed to position papers of these societies on air pollution and climate change. She consults extensively with the WHO, the European Union and the French government on various public health problems. She has served on the editorial boards of numerous medical journals and book series for 20 years. She is the authors of more than 400 peer-reviewed papers, reviews and chapters in books. Her H factor is 50 and her works have had about 11,000 citations. Professor Annesi-Maesano is a respiratory epidemiologist by training through a PhD, a DSc and postdoctoral research (Department of Public Health Sciences at St George's Hospital, London, UK) in epidemiology and public health. She graduated in physics (Rome) and medicine (Paris). Antonella CianferoniAntonella CianferoniAntonella Cianferoni is an associate professor of Pediatrics at the University of Pennsylvania, USA, and an attending physician in the allergy and immunology division at the Children's Hospital of Philadelphia, USA. She is an ABAI certified, practicing pediatric allergist with a special clinical and research interest in food allergy and eosinophilic esophagitis, and has had extensive training in molecular biology and clinical studies. Currently, she splits her time evenly between clinical practice and research activities. Her research has been funded by NIH, APFED, AAAAI/APFED 2015 HOPE/ARTrust, AAAAI, Foederer. Dr Cianferoni is in the leadership of the AAAAI as she is the current BCI secretary, and she is also the secretary of the working groups for Eosinophilic Esophagitis for the EAACI. She is the co-director of the FARE center at the Children's Hospital of Philadelphia. Dr Cianferoni graduated from University of Florence's medical school, Italy, where she also obtained her PhD in pediatric immunology. She has completed a residency school in pediatrics at the A Meyer Hospital, University of Florence, and one at the Children's Hospital of Philadelphia. She has also done a research fellowship at Johns Hopkins Allergy and Asthma Center and a clinical allergy and immunology fellowship at the Boston's Children's Hospital, USA. Since joining the Allergy and Immunology Faculty in the Department of Pediatrics of the University of Pennsylvania, Perelman Medical School at the Children's Hospital of Philadelphia in 2007, she has started a laboratory that has focused on understanding how iNKT cells can contribute to food allergy pathogenesis including EoE (Jyonouchi et al JACI 2011, Jyonouchi et al Clinical Experimental allergy) and has expanded her research to understand the role of conventional and regulatory T cell (Treg) in EoE (Cianferoni et al, Ann Allergy Asthma Immunol. 2018). She is currently coordinating the T cell studies for CEGIR. She contributed to the recent identification of TSLP, EMSY and CAPN14 as a genetic risk factor by Genome Wide Association Studies (Rothenberg M, Spergel JM et al Nature Genetics 2010, Sleiman P et al Nature Communications 2014), and to the characterization of TSLP and EMSY in Eosinophilic esophagitis pathogenesis (Siracusa et al Nature 2011, Noti et al Nature Medicine 2013, Siracusa et la Immunity 2014, Fahey LM et al, Pediatr Allergy Immunol. 2018). She has also studied the genetic risk factors for the development of a specific subtype of EoE (Fahey LM et al, Clin Transl Gastroenterol. 2018). Dr Cianferoni is also involved in clinical studies and she is currently the PI in the first world study for the evaluation of epicutaneous immunotherapy for milk desensitization in children with milk induced EoE (SMILEE, DBV), and the site PI for the study for the development of topical budesonide (SHP621-301, SHIRE). She is also a subinvestigator in many other clinical trials for oral and epicutaneous desensitization (VIPES-DBV, MILES-DBV, ARC-Alloimune, Multifood Xolair). As a postdoctoral fellow at the Hopkins Allergy and Asthma's center first and then the Children's Hospital in Boston, Dr Cianferoni worked on transcriptional regulation of IL-4 and IL-2. The results of her research were published in Blood and JACI. She has also clinically characterized several classical allergic diseases such as anaphylaxis, food allergy, hymenoptera venom hypersensitivity, atopic dermatitis, and asthma. She has extensively studied anaphylactic reaction in children and adults, and the outcome of food challenges in children.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.